Access
To read this story in full you will need to login or make a payment (see right).
Technical Report
Nature Medicine 12, 452 - 458 (2006)
Published online: 2 April 2006 | doi:10.1038/nm1394
Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts
Wolfram-Hubertus Zimmermann1,6, Ivan Melnychenko1,6, Gerald Wasmeier2, Michael Didié1, Hiroshi Naito1, Uwe Nixdorff2, Andreas Hess3, Lubos Budinsky3, Kay Brune3, Bjela Michaelis4, Stefan Dhein4, Alexander Schwoerer5, Heimo Ehmke5 & Thomas Eschenhagen1
Abstract
The concept of regenerating diseased myocardium by implantation of tissue-engineered heart muscle is intriguing, but convincing evidence is lacking that heart tissues can be generated at a size and with contractile properties that would lend considerable support to failing hearts. Here we created large (thickness/diameter, 1–4 mm/15 mm), force-generating engineered heart tissue from neonatal rat heart cells. Engineered heart tissue formed thick cardiac muscle layers when implanted on myocardial infarcts in immune-suppressed rats. When evaluated 28 d later, engineered heart tissue showed undelayed electrical coupling to the native myocardium without evidence of arrhythmia induction. Moreover, engineered heart tissue prevented further dilation, induced systolic wall thickening of infarcted myocardial segments and improved fractional area shortening of infarcted hearts compared to controls (sham operation and noncontractile constructs). Thus, our study provides evidence that large contractile cardiac tissue grafts can be constructed in vitro, can survive after implantation and can support contractile function of infarcted hearts.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarctionNature Medicine Technical Report (01 Apr 2006)
Granulocyte colony-stimulating factor improves left ventricular function of doxorubicin-induced cardiomyopathyLaboratory Investigation Research Article
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failureNature Medicine Article (01 Oct 1999)
Neovascularization of ischemic myocardium by human bone-marrow?derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac functionNature Medicine Article (01 Apr 2001)
Endothelial-to-mesenchymal transition contributes to cardiac fibrosisNature Medicine Article (01 Aug 2007)
See all 7 matches for Research